Smokers visit their GP nearly a third more frequently than non-smokers, and smoking contributes to almost half a million hospital admissions annually. Supporting people to quit smoking for good will not only improve individuals’ health, but also alleviate demands on the UK’s healthcare systems.
Our smoking cessation programme offers a comprehensive solution to empower patients on their journey to becoming smoke-free. Designed by experts and backed by clinical evidence, our programmes and workshops provide tailored support to ensure long-term success in quitting smoking.
Join us in championing the first smoke-free generation with our proactive approach to smoking cessation. Our programmes combine personalised behaviour change techniques, Nicotine Replacement Therapy, medication, and e-cigarettes to provide patients with a holistic toolkit for quitting smoking on their terms.
Tailored to meet diverse patient needs, our specialised programmes cater to individuals such as pregnant women, young adults, manual workers, and those managing Chronic Obstructive Pulmonary Disease (COPD), Coronary Heart Disease (CHD), or mental health concerns. Each programme is carefully crafted with custom content and delivery methods to maximise patient success.
Delivered by specialist health and wellbeing practitioners, Xyla has a proven track record in delivering impactful stop-smoking campaigns and tobacco-related awareness workshops for young people and adults. We offer personalised quit vaping programmes that leverage behaviour change techniques, ensuring patients achieve lasting results and improved health outcomes.
To explore how our services could empower your communities to live healthier lives, for longer, please get in touch.
Xyla is a trading name of ICS Operations Ltd (Registered No 4793945), Pulse Healthcare Limited (Registered No 3156103), Carehome Selection Limited (Registered No 3091598), Independent Clinical Services Limited (Registered No 4768329) and CHS Healthcare Software Limited (Registered No 11582111)